Aylin Yilmaz Selected Research

Blood Proteins (Serum Proteins)

1/2021

Proteomic blood profiling in mild, severe and critical COVID-19 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aylin Yilmaz Research Topics

Disease

13	Infections 05/2024 - 03/2006
11	COVID-19 11/2023 - 01/2020
8	HIV Infections (HIV Infection) 04/2024 - 02/2012
4	Dementia (Dementias) 05/2024 - 01/2017
2	Persistent Infection 05/2024 - 02/2023
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Central Nervous System Infections (Central Nervous System Infection) 01/2019 - 12/2010
2	Viremia 01/2017 - 12/2010
1	Multiple Sclerosis 04/2024
1	Meningitis 11/2023
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Cognitive Dysfunction 01/2022
1	Vitamin B Deficiency 01/2022
1	Heart Injuries 01/2021
1	Disease Progression 01/2021
1	Heart Failure 01/2021
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Frontotemporal Dementia (Semantic Dementia) 01/2019
1	Lewy Body Disease (Lewy Body Dementia) 01/2019
1	Malnutrition (Nutritional Deficiencies) 01/2018
1	Uterine Cervical Dysplasia 01/2018
1	Rupture 01/2018
1	Adenocarcinoma in Situ 01/2018
1	Exocrine Pancreatic Insufficiency 01/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018
1	Atherosclerosis 03/2014
1	Obesity 08/2013
1	Insulin Resistance 08/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2013
1	Overweight 08/2013
1	Cryptococcal Meningitis 09/2012

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2018
6	RNA (Ribonucleic Acid)IBA 05/2024 - 12/2010
5	Immunoglobulin G (IgG)IBA 04/2024 - 03/2014
4	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2017
3	Viral RNAIBA 10/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2017
2	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2019 - 01/2019
2	NeopterinIBA 01/2019 - 01/2017
2	Drug CombinationsIBA 01/2018 - 03/2006
1	ProteomeIBA 05/2024
1	Cerebrospinal Fluid ProteinsIBA 05/2024
1	Immunoglobulins (Immunoglobulin)IBA 04/2024
1	remdesivirIBA 10/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022
1	Betamethasone (Celestone)FDA Link 10/2022
1	Oxygen (Dioxygen)IBA 10/2022
1	HomocysteineIBA 01/2022
1	Viral AntigensIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	chloroquine diphosphate FDA LinkGeneric 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	AntibodiesIBA 01/2020
1	Glial Fibrillary Acidic ProteinIBA 01/2020
1	RacivirIBA 11/2019
1	FumaratesIBA 11/2019
1	Tenofovir (Viread)FDA Link 11/2019
1	Emtricitabine (Emtriva)FDA Link 11/2019
1	lamivudine drug combination abacavir FDA Link 11/2019
1	emtricitabine tenofovir alafenamideIBA 11/2019
1	NeurograninIBA 01/2019
1	CytokinesIBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	oxidized low density lipoproteinIBA 03/2014
1	Immunoglobulin M (IgM)IBA 03/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2014
1	EpitopesIBA 03/2014
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 08/2013
1	efavirenz (Sustiva)FDA Link 09/2012
1	Raltegravir Potassium FDA Link 09/2009

Therapy/Procedure

7	Therapeutics 02/2023 - 12/2010
4	Art Therapy 02/2023 - 01/2017
2	Critical Care (Surgical Intensive Care) 11/2023 - 01/2022
1	Contraindications 01/2018
1	Aftercare (After-Treatment) 01/2018